Yasmine El Chazli
Overview
Explore the profile of Yasmine El Chazli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moaaz M, Badreldin O, El Chazli Y, Fata A, Abougabal M
Pediatr Pulmonol
. 2023 Jun;
58(9):2543-2550.
PMID: 37283241
The aim of this study was to assess pulmonary dysfunction in children with transfusion-dependent thalassemia (TDT) using the Global Lung Function Initiative (GLI) 2022 race-neutral spirometric reference equations and to...
2.
Li M, Fischer J, Safwat S, Shoman W, El Chazli Y, Alter S, et al.
Pediatr Dermatol
. 2023 Jan;
40(1):113-119.
PMID: 36670503
Background/objectives: Lipoid proteinosis (LP) is a rare autosomal recessive multisystem disorder that is caused by loss-of-function pathogenic variants in the extracellular matrix protein-1 (ECM1) gene. The typical clinical manifestations of...
3.
Hassab H, Hanafi M, ElBeheiry A, Hassan M, El Chazli Y
Indian J Pediatr
. 2022 Jul;
90(2):146-152.
PMID: 35781614
Objectives: To evaluate the relationship between TGFBR3 rs284875 single nucleotide polymorphism (SNP) state and silent cerebral infarction (SCI) in asymptomatic patients with sickle cell disease (SCD). Methods: A cross-sectional study...
4.
Reyad F, Elsayed N, El Chazli Y
Oral Dis
. 2022 Apr;
29(5):2239-2247.
PMID: 35460304
Objectives: Evaluation of the effectiveness of Photobiomodulation(PBM) for chemotherapy-induced oral mucositis (OM) in leukemic children. Materials And Methods: A randomized controlled clinical study including forty-four leukemic children diagnosed with chemotherapy-induced...
5.
Barakat S, Assem H, Salama M, Mikhael N, El Chazli Y
J Egypt Natl Canc Inst
. 2022 Apr;
34(1):17.
PMID: 35434757
Background: Repeated high-dose methotrexate (HDMTX) is a critical component of contemporary childhood acute lymphoblastic leukemia (ALL) treatment regimens. Serum albumin is considered a carrier of methotrexate (MTX) in the blood....
6.
Hassan E, Nagui Rizk D, Aly N, El Chazli Y
Pediatr Hematol Oncol
. 2021 May;
38(8):683-694.
PMID: 33974490
Since the World Health Organization declared the COVID-19 pandemic in March 2020, the strain on healthcare services affected patients suffering from various comorbidities and added to the psychological burden. The...
7.
Hassan E, Foulath G, Abdelghany M, Sayed I, Elkhity D, El Chazli Y
Indian J Pediatr
. 2020 Nov;
88(9):859-863.
PMID: 33216322
Objectives: The authors aim to assess the use of investigations for patients with acute hemolytic anemia due to glucose-6-phosphate dehydrogenase (G6PD) deficiency and to ensure guidelines application during practice to...
8.
Elsharkawy A, Assem H, Salama M, Mikhael N, Zeid M, El Chazli Y
Pediatr Hematol Oncol
. 2020 Nov;
38(3):194-207.
PMID: 33150824
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition, arising either due to genetic mutations or from a variety of underlying diseases. This prospective observational study reports the clinical and laboratory data...
9.
Blincoe A, Heeg M, Campbell P, Hines M, Khojah A, Klein-Gitelman M, et al.
J Clin Immunol
. 2020 Jul;
40(6):901-916.
PMID: 32638196
Isolated neuroinflammatory disease has been described in case reports of familial hemophagocytic lymphohistiocytosis (FHL), but the clinical spectrum of disease manifestations, response to therapy and prognosis remain poorly defined. We...